Gilead Sciences, Inc.

NASDAQ:GILD ISIN:US3755581036

Gilead Sciences, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of human therapeutics for life threatening diseases.

View in Other Languages

News

Agenix Limited (ASX:AGX) Signed New China Agreements to Advance Lead Drug Candidate and New Product Pipeline

🕔10/13/2011 8:26:00 AM 9349

Agenix Limited (ASX:AGX) today confirmed it had signed two new agreements with its strategic partners in China covering the commercialisation of new drug candidates, the sharing of resources, expertise and completion of pre-clinical toxicology tests for its new hepatitis B drug in China.

Read Full Article▸

Agenix Limited (ASX:AGX) Showcase Promising New Low-Risk Hepatitis Drug for China Market at Bio Korea 2011

🕔9/30/2011 2:32:45 PM 10229

Agenix Limited (ASX:AGX) confirmed its promising new hepatitis B drug, AGX-1009, shared the same active compound as Gilead's blockbuster drug, Viread, which is widely used to treat HIV and hepatitis throughout Asia.